These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29651881)

  • 1. Oxidative stress in epilepsy.
    Geronzi U; Lotti F; Grosso S
    Expert Rev Neurother; 2018 May; 18(5):427-434. PubMed ID: 29651881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting oxidative stress component in the therapeutics of epilepsy.
    Azam F; Prasad MV; Thangavel N
    Curr Top Med Chem; 2012; 12(9):994-1007. PubMed ID: 22352862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative injury in epilepsy: potential for antioxidant therapy?
    Costello DJ; Delanty N
    Expert Rev Neurother; 2004 May; 4(3):541-53. PubMed ID: 15853548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers.
    Devi PU; Manocha A; Vohora D
    Expert Opin Pharmacother; 2008 Dec; 9(18):3169-77. PubMed ID: 19040338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidants Targeting Mitochondrial Oxidative Stress: Promising Neuroprotectants for Epilepsy.
    Yang N; Guan QW; Chen FH; Xia QX; Yin XX; Zhou HH; Mao XY
    Oxid Med Cell Longev; 2020; 2020():6687185. PubMed ID: 33299529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach.
    Upaganlawar AB; Wankhede NL; Kale MB; Umare MD; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Najda A; Nurzyńska-Wierdak R; Bungau S; Behl T
    Biomed Pharmacother; 2021 Nov; 143():112146. PubMed ID: 34507113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on the development of antioxidant antiepileptogenic agents.
    Rowles J; Olsen M
    Mini Rev Med Chem; 2012 Sep; 12(10):1015-27. PubMed ID: 22512592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic drugs and neuroprotection: current status and future roles.
    Willmore LJ
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of flavonoids on oxidative stress in epilepsy.
    Diniz TC; Silva JC; de Lima-Saraiva SR; Ribeiro FP; Pacheco AG; de Freitas RM; Quintans-Júnior LJ; Quintans Jde S; Mendes RL; Almeida JR
    Oxid Med Cell Longev; 2015; 2015():171756. PubMed ID: 25653736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection.
    Pandey AK; Patnaik R; Muresanu DF; Sharma A; Sharma HS
    Int Rev Neurobiol; 2012; 102():107-46. PubMed ID: 22748828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection possibilities in epileptic children.
    Artemowicz B; Sobaniec W
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():91-5. PubMed ID: 16119636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antiepileptic drugs in free radicals generation and antioxidant levels in epileptic patients.
    Eldin EE; Elshebiny HA; Mohamed TM; Abdel-Aziz MA; El-Readi MZ
    Int J Neurosci; 2016; 126(2):105-15. PubMed ID: 25539180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish oil provides protection against the oxidative stress in pilocarpine model of epilepsy.
    Nejm MB; Haidar AA; Marques MJ; Hirata AE; Nogueira FN; Cavalheiro EA; Scorza FA; Cysneiros RM
    Metab Brain Dis; 2015 Aug; 30(4):903-9. PubMed ID: 25893881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drugs in neuroprotection.
    Pitkänen A; Kubova H
    Expert Opin Pharmacother; 2004 Apr; 5(4):777-98. PubMed ID: 15102563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis.
    Singh N; Vijayanti S; Saha L
    Int J Neurosci; 2018 Oct; 128(10):987-994. PubMed ID: 29447051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V; Pierguidi L; Tambasco N
    Brain Dev; 2011 Apr; 33(4):289-93. PubMed ID: 20630672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of epilepsy].
    Legido A
    Rev Neurol; 2002 Jan 16-31; 34(2):186-95. PubMed ID: 11988916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
    Grewal GK; Kukal S; Kanojia N; Saso L; Kukreti S; Kukreti R
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.